Conditions
Conditions
- Cancer prevention
- Cancer treatment
- Lung cancer
- Breast cancer
- Leukemia
- Autoimmune diseases
- Type 1 diabetes
- Lupus
- Multiple Sclerosis
- Crohn's disease
- Inflammatory conditions
- Inflammatory bowel disease
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Chronic bronchitis
- Infectious diseases
- Hepatitis B and C
- HIV
- Cardiovascular diseases
- Stroke
- Hypertension
- Heart failure
- Ischemic heart disease
- Peripheral artery disease
- Neurological disorders
- Traumatic brain injury
- Parkinson's disease
- Spinal Cord Injury
- Autism
- Skin and soft tissue conditions
- Anti-Aging
- Burns and wounds
- Skin ulcers
- Acne scars
- Hair loss
- Psoriasis
- Eczema
- Vitiligo
- Hyperpigmentation
- Metabolic disorders
- Obesity
- Diabetes Type 2
- Eye disorders
- Macular degeneration
- Retinal diseases
- Organ damage
- Liver cirrhosis
- Chronic Kidney Disease
- Renal failure
- Limb ischemia
- Chronic pain syndromes
- Fibromyalgia
- Chronic headaches
- Inherited disorders
- Muscular dystrophy
- Cystic Fibrosis
- Psychiatric conditions
- Depression
- Anxiety disorders
- Reproductive health
- Male and female infertility
- Erectile dysfunction
- Menopause
Chronic Kidney Disease
Stem Cell Therapy for Kidney Disease
The prevalence of kidney diseases has become a critical public health concern. In the United States alone, an estimated 37 million people are impacted by chronic kidney disease (CKD), with a staggering 90% unaware of their condition. To compound the issue, the 5-year survival rate for kidney failure falls below 50%.
However, this survival rate can dramatically rise to 80% if a patient receives a kidney transplant. Unfortunately, the process of finding a compatible donor match can often take up to three long years and the costs are very high. While awaiting a transplant, most patients must endure weekly dialysis. The good news is that stem cells are emerging as a promising solution for kidney disease treatment.
The Potential of Stem Cells in Kidney Disease
Mesenchymal stem cells, with their remarkable ability to repair damaged tissues, serve as the body’s innate defense against kidney damage. When administered to patients, these cells have the power to shield the kidneys from injury and expedite the healing process. The efficacy of stem cell therapy in addressing acute and chronic kidney diseases has been substantiated through numerous preclinical studies. Clinical trials have further demonstrated the safety of MSC transplantation for patients with kidney disease.
